Catalogo dei prodotti della ricerca

FALCONE, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.386
AS - Asia 3.916
EU - Europa 2.755
SA - Sud America 622
Continente sconosciuto - Info sul continente non disponibili 494
AF - Africa 191
OC - Oceania 6
Totale 16.370
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.213
SG - Singapore 1.523
IT - Italia 1.348
CN - Cina 637
HK - Hong Kong 504
BR - Brasile 448
VN - Vietnam 447
IN - India 370
DE - Germania 288
FI - Finlandia 237
SE - Svezia 149
RU - Federazione Russa 137
FR - Francia 129
GB - Regno Unito 110
BD - Bangladesh 109
CA - Canada 109
AR - Argentina 85
UA - Ucraina 63
NL - Olanda 59
ZA - Sudafrica 57
IE - Irlanda 56
JP - Giappone 51
TG - Togo 44
IQ - Iraq 43
AT - Austria 37
ID - Indonesia 31
TR - Turchia 27
PK - Pakistan 26
EC - Ecuador 24
PL - Polonia 23
BG - Bulgaria 21
MX - Messico 21
MA - Marocco 20
CO - Colombia 18
RO - Romania 18
BE - Belgio 17
ES - Italia 15
PH - Filippine 14
SA - Arabia Saudita 14
MY - Malesia 13
PY - Paraguay 12
VE - Venezuela 12
KE - Kenya 11
AE - Emirati Arabi Uniti 10
EG - Egitto 10
JO - Giordania 10
CL - Cile 9
CR - Costa Rica 9
JM - Giamaica 9
NP - Nepal 9
TN - Tunisia 9
UY - Uruguay 9
AZ - Azerbaigian 8
KR - Corea 8
LT - Lituania 7
OM - Oman 7
TT - Trinidad e Tobago 7
UZ - Uzbekistan 7
CH - Svizzera 6
ET - Etiopia 6
IL - Israele 6
PS - Palestinian Territory 6
BH - Bahrain 5
BJ - Benin 5
LB - Libano 5
PT - Portogallo 5
SC - Seychelles 5
TH - Thailandia 5
AL - Albania 4
AO - Angola 4
CI - Costa d'Avorio 4
IR - Iran 4
NI - Nicaragua 4
SN - Senegal 4
TW - Taiwan 4
BZ - Belize 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
GR - Grecia 3
KG - Kirghizistan 3
MN - Mongolia 3
NZ - Nuova Zelanda 3
PE - Perù 3
RS - Serbia 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DZ - Algeria 2
EU - Europa 2
GT - Guatemala 2
LV - Lettonia 2
MD - Moldavia 2
NG - Nigeria 2
NO - Norvegia 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AM - Armenia 1
BB - Barbados 1
BS - Bahamas 1
Totale 15.856
Salva come PNG Salva come JPEG
Città #
Fairfield 999
Ashburn 849
Singapore 765
Dearborn 515
San Jose 500
Hong Kong 491
Woodbridge 443
Seattle 411
Houston 376
Cambridge 323
Rome 315
Wilmington 285
Milan 281
Chandler 254
Ann Arbor 199
Los Angeles 179
Princeton 156
San Paolo di Civitate 156
Ho Chi Minh City 151
Beijing 150
Santa Clara 142
Council Bluffs 134
Plano 124
Cosenza 123
Dallas 122
Hanoi 106
The Dalles 105
Buffalo 101
Lawrence 100
Lauterbourg 94
Helsinki 88
Frankfurt am Main 83
Millbury 74
New York 71
Boston 65
Dublin 55
Phoenix 55
São Paulo 49
Munich 48
Lomé 44
San Diego 44
Figino 43
Johannesburg 40
Tokyo 40
Fremont 38
Moscow 38
Hefei 37
Toronto 35
Chicago 34
Andover 33
Turku 33
Federal 32
Orem 31
Des Moines 28
Falkenstein 26
Redondo Beach 26
Atlanta 25
Falls Church 25
London 25
Ottawa 24
Vienna 23
Norwalk 21
Sofia 21
Jakarta 20
Hillsboro 19
Guangzhou 18
Warsaw 18
Rio de Janeiro 17
Brussels 16
Haiphong 16
Jacksonville 16
Montreal 16
Naaldwijk 16
Dhaka 15
Clementon 14
Da Nang 14
Mannheim 14
Nanjing 14
Naples 14
Baghdad 13
Boardman 13
Nuremberg 13
Bremen 12
Casablanca 12
Denver 12
Miano 12
Yubileyny 12
Campinas 11
Elk Grove Village 11
San Mateo 11
Stockholm 11
Belo Horizonte 10
Bengaluru 10
Biên Hòa 10
Brooklyn 10
Bến Tre 10
Lahore 10
Shanghai 10
Columbus 9
Kunming 9
Totale 10.791
Salva come PNG Salva come JPEG
Nome #
Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirin 246
Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia 231
Impaired flow-mediated dilation in hospitalized patients with community-acquired pneumonia 227
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 211
Expanded CURB-65: A new score system predicts severity of community-acquired pneumonia with superior efficiency 201
Corticosteroid use and incident myocardial infarction in adults hospitalized for community-acquired pneumonia 192
Platelet activation is associated with myocardial infarction in patients with pneumonia 190
Cardiovascular complications and short-term mortality risk in community-acquired pneumonia 187
Candidaemia after heart valve replacement surgery. Recurrence as prosthetic valve endocarditis is an expected over one-year complication 186
Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae 181
Risk factors and outcomes for bloodstream infections secondary to Clostridium difficile infection 178
Is NOX2 upregulation implicated in myocardial injury in patients with pneumonia? 178
Cirrhotic patients are at risk for health care-associated bacterial infections. 174
Nursing home residence is associated with spread of Clostridium difficile ribotype 027 in central Italy 174
Hemostatic balance in patients with liver cirrhosis. report of a consensus conference 172
Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal medicine wards. a multicenter study 172
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 172
A cluster of fulminant Clostridium difficile colitis in an intensive care unit in Italy 169
Acute bacterial skin and skin structure infections in internal medicine wards. old and new drugs 168
Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia 167
An empirical broad spectrum antibiotic therapy in Healthcare-Associated infections improves survival in cirrhotics. A randomized trial 165
The ADA (age-d-dimer-albumin) score to predict thrombosis in SARS-CoV-2 165
Candidemia in patients with body temperature below 37°C and admitted to internal medicine wards. Assessment of risk factors 162
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study 161
Association between PaO2/FiO2 ratio and thrombotic events in COVID-19 patients 158
Septic bilateral pulmonary candidiasis successfully treated with anidulafungin therapy in two patients with peritoneal carcinomatosis 150
Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia 150
Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience 149
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey 146
A predictive model of mortality in patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae 145
Clinical experience of anidulafungin for the treatment of patients with documented candidemia. 142
Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy 141
Pneumonia in frail older patients: an up to date. 141
The relationship between cardiac injury, inflammation and coagulation in predicting COVID-19 outcome 141
Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection 140
Surgical debridement with muscle flap transposition and systemic teicoplanin therapy for infected hip arthroplasty 140
Testis sparing surgery for small testicular masses. Retrospective analysis of a multi-center cohort 138
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 135
Early, intermediate and late infectious complications after transcatheter or surgical aortic-valve replacement: a prospective cohort study 133
Hospitalization for pneumonia is associated with decreased 1-year survival in patients with type 2 diabetes results from a prospective cohort study 133
Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia. 132
Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia 132
Candidemia Subsequent to Severe Infection Due to Clostridium difficile: Is There a Link? 129
Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience 129
Corticosteroid use, myocardial injury and in-hospital cardiovascular events in patients with community-acquired pneumonia 128
Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: an observational study from Italy, 2020-21 128
Reply to: "The possible role of anti-methicillin-resistant Staphylococus aureus antimicrobial agents in spontaneous bacterial peritonitis" 126
Candidal thrombophlebitis of central veins: case report and review 125
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL). Consensus proposal for management 122
Streptococcus anginosus group disseminated infection: case report and review of literature. 121
Topical nystatin prophylaxis: a likely viable measure for reducing impact of candidemia in neurosurgical patients with early tracheostomy intubation 121
Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study. 120
Clinical impact of broad-spectrum empirical antibiotic therapy in patients with healthcare-associated pneumonia: a multicenter interventional study. 120
Role of aspirin in patients with septic shock. a complex and intriguing relationship 118
Predictors of mortality in non-neutropenic patients with invasive pulmonary aspergillosis. Does galactomannan have a role? 117
Teicoplanin use and emergence of Staphylococcus haemolyticus: is there a link? 116
Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. 116
Surveillance and management of multidrug-resistant microorganisms 115
[Linezolid therapy for the treatment of nocardial infection: report of a case and review of the literature]. 114
A case of Lactobacillus casei bacteraemia associated with aortic dissection: is there a link? 113
Ampicillin Plus Ceftriaxone Is as Effective as Ampicillin Plus Gentamicin for Treating Enterococcus faecalis Infective Endocarditis 113
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 113
[Staphylococcus aureus sepsis in hospitalized non neutropenic patients: retrospective clinical and microbiological analysis]. 112
Daptomycin plus trimethoprim/sulfamethoxazole combination therapy in post-neurosurgical meningitis caused by linezolid-resistant Staphylococcus epidermidis 112
[Piperacillin-tazobactam in the treatment of severe nosocomial infections]. 111
In vitro activity of daptomycin against methicillin- and multi-resistant Staphylococcus haemolyticus invasive isolates carrying different mec complexes 110
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients 110
Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary? 109
Compassionate use of meropenem/vaborbactam for infections caused by kpc-producing Klebsiella pneumoniae. A multicentre study 108
Changing Italian nosocomial-community trends and heteroresistance in Staphylococcus aureus from bacteremia and endocarditis. 107
Staphylococcus haemolyticus endocarditis: clinical and microbiologic analysis of 4 cases 106
CAP and HCAP are different? An unresolved question 105
Low-grade endotoxemia and clotting activation in the early phase of pneumonia 105
Conservative medical therapy of infections following osteosynthesis: A retrospective analysis of a six-year experience 104
Early identification of severe community-onset pneumonia in "frail elderly patient". 104
Simplified Equations Using Two Concentrations To Calculate Area under the Curve for Antimicrobials with Concentration-Dependent Pharmacodynamics: Daptomycin as a Motivating Example 104
Functional outcomes following immediate repair of penile fracture: a tertiary referral centre experience with 76 consecutive patients 103
Identification and management of invasive mycoses in internal medicine: a road-map for physicians 102
Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study 101
Healthcare-associated pneumonia: Diagnostic criteria and distinction from community-acquired pneumonia 101
In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy 101
Methicillin-resistant staphylococcal bacteremia in patients with hematologic malignancies: clinical and microbiological retrospective comparative analysis of S. haemolyticus, S. epidermidis and S. aureus 100
Role of multidrug-resistant pathogens in health-care-associated pneumonia 100
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 100
Severe community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infection. 99
Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI) 98
Serious infections due to methicillin-resistant Staphylococcus aureus: an evolving challenge for physicians. 98
Worrisome Trend of New Multiple Mechanisms of Linezolid Resistance in Staphylococcal Clones Diffused in Italy 97
Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia 97
Health care associated pneumonia: a new clinical entity. 96
Candida Infective Endocarditis Report of 15 Cases From a Prospective Multicenter Study 95
Infections with VIM-1 metallo-{beta}-lactamase-producing enterobacter cloacae and their correlation with clinical outcome. 94
Healthcare-associated pneumonia: a never-ending story. 94
Risk factors and clinical significance of endemic ertapenem resistant Klebsiella pneumoniae isolates in hospitalized patients 94
Reply: Platelet ACTIVATION and PNEUMONIA: Is soluble P-selectin the right marker? 94
Invasive aspergillosis in patients with liver disease 94
Successful Ertapenem-Doripenem Combination Treatment of Bacteremic Ventilator-Associated Pneumonia Due to Colistin-Resistant KPC-Producing Klebsiella pneumoniae 93
Infectious aortitis and spondylodiscitis in patients with endovascular stents 93
Risk factors and outcomes of endocarditis due to non-HACEK Gram-negative bacilli: data from the prospective multicenter SEI cohort 92
Role of empirical and targeted therapy in hospitalized patients with bloodstream infections caused by ESBL-producing Enterobacteriaceae 91
Totale 13.213
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.812
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.812
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.266 0 0 141 44 164 29 37 159 110 94 207 281
2022/20231.253 270 362 63 114 112 96 20 50 84 7 50 25
2023/2024604 43 84 37 58 47 56 15 45 6 80 63 70
2024/20252.284 65 64 104 58 132 131 128 81 516 231 177 597
2025/20265.214 563 194 387 450 600 296 836 389 366 561 276 296
2026/2027928 284 558 86 0 0 0 0 0 0 0 0 0
Totale 16.370